Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

NCT02993068 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02993068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Suspended
Start date
April 18, 2017
Completion date
April 18, 2028
Enrollment
5,200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bard1 gene mutation, brca1 gene mutation, brca2 gene mutation, brip1 gene mutation, estrogen receptor negative, her2/neu negative, mlh1 gene mutation, msh2 gene mutation, msh6 gene mutation, palb2 gene mutation, pms2 gene mutation, progesterone receptor negative, rad51c gene mutation, rad51d gene mutation, triple-negative breast carcinoma